+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Faropenem Sodium Market by Form, Pack Size, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032- Product Image
Faropenem Sodium Market by Form, Pack Size, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032- Product Image
Sale

Faropenem Sodium Market by Form, Pack Size, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454934
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Faropenem Sodium Market is projected to reach USD 277.10 Million in 2026. It is expected to continue growing at a CAGR of 7.45%, reaching USD 427.87 Million by 2032.

Faropenem sodium is an oral penem-class beta-lactam antibiotic positioned for treatment settings where clinicians need broad activity against selected Gram-positive, Gram-negative, and anaerobic organisms while preserving parenteral carbapenems for severe infections. Its relevance is tied to antimicrobial resistance, outpatient infection management, and the continued need for oral options that support appropriate antibiotic stewardship.

The commercial landscape remains specialized rather than universal. Faropenem has established clinical and market visibility in select Asian markets, while it is not broadly approved across major Western regulatory systems such as the United States. For SEO and market intelligence purposes, the most important keywords include Faropenem Sodium, oral penem antibiotic, beta-lactam antibiotics, antimicrobial resistance, bacterial infection treatment, and antibiotic stewardship.

Transformative Shifts in the Landscape

The Faropenem Sodium landscape is being reshaped by three forces: resistance surveillance, regulatory scrutiny, and the need for evidence-based prescribing. Health systems are increasingly aligning antibiotic access with stewardship rules, susceptibility testing, and local treatment guidelines rather than broad empirical expansion.

A second shift is the migration of value from simple product availability to differentiated clinical positioning. Suppliers, manufacturers, and commercial partners must now demonstrate reliable quality, pharmacovigilance readiness, and responsible marketing. In markets where faropenem is available, demand is most defensible when supported by microbiology data and clear use cases across respiratory, urinary, skin, soft tissue, dental, and other physician-directed bacterial infections.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative accelerator across the Faropenem Sodium value chain, especially in antimicrobial resistance monitoring, prescribing analytics, and manufacturing quality control. AI-enabled surveillance can help correlate local susceptibility patterns with prescribing behavior, supporting more precise use of oral beta-lactam antibiotics.

In research and development, machine learning can assist with beta-lactam structure-activity analysis, resistance mechanism mapping, and formulation optimization. In commercial operations, AI can improve demand forecasting, detect supply disruptions, and support pharmacovigilance signal triage. The strongest long-term impact will come from combining AI with laboratory-confirmed susceptibility data and clinically governed antibiotic stewardship programs.

Key Regional Insights

Asia-Pacific is the most strategically relevant region for Faropenem Sodium because of higher familiarity with oral penem therapy in countries such as Japan and India, combined with large outpatient infection volumes, domestic pharmaceutical manufacturing depth, and expanding diagnostic capacity. North America remains more constrained because faropenem is not approved by the U.S. Food and Drug Administration, making the region more relevant for regulatory benchmarking, clinical research, and antimicrobial stewardship intelligence than immediate broad commercialization.

Europe is shaped by rigorous antimicrobial stewardship, centralized quality expectations, pharmacovigilance discipline, and country-level reimbursement controls, while Latin America presents selective opportunities where regulatory pathways, private healthcare expansion, and physician education can support responsible access. The Middle East, particularly advanced Gulf health systems, is increasingly focused on formulary governance, centralized procurement, and infection-control standards, whereas Africa requires access strategies that balance affordability, quality assurance, antimicrobial resistance monitoring, and sustainable distribution across diverse healthcare systems.

Key Group Insights

ASEAN markets provide growth potential where expanding healthcare access, private hospital networks, and rising diagnostic adoption support demand for effective oral antibiotics, although stewardship policies and regulatory maturity vary by country. The GCC is characterized by centralized procurement, strong hospital governance, and growing antimicrobial resistance programs, making clinical evidence, formulary alignment, and supply reliability decisive for adoption.

The European Union emphasizes regulatory discipline, pharmacovigilance, and antimicrobial stewardship, while BRICS countries combine high infection burden with major generic manufacturing capability, large treatment volumes, and diverse regulatory maturity. G7 markets set the benchmark for clinical evidence, quality standards, reimbursement scrutiny, and responsible antibiotic commercialization. NATO-aligned countries are also strengthening medical supply resilience, which can elevate interest in diversified antibiotic sourcing without weakening stewardship controls or evidence-based prescribing requirements.

Key Country Insights

The United States is primarily a reference market for regulatory rigor because faropenem does not have FDA approval, while Canada similarly emphasizes evidence-based authorization and antimicrobial stewardship. Mexico and Brazil offer selective opportunities through expanding private healthcare, infectious disease treatment demand, and evolving regulatory oversight, but require careful registration, pricing, physician education, and quality positioning. In Europe, the United Kingdom, Germany, France, Italy, and Spain are governed by strict antibiotic stewardship, reimbursement scrutiny, and prescribing governance, while Russia presents a distinct regulatory, procurement, and supply-chain environment.

China and India are central to Asia-Pacific evaluation because they combine large patient populations, domestic pharmaceutical manufacturing, high outpatient antibiotic utilization, and heightened antimicrobial resistance concerns. Japan remains highly relevant due to established faropenem experience and disciplined prescribing frameworks. Australia and South Korea reflect advanced regulatory expectations, strong hospital stewardship, sophisticated diagnostics, and high pharmacovigilance standards, making them attractive for evidence-driven positioning rather than broad, promotion-led expansion.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize responsible market development over volume-only expansion. The strongest strategy is to align Faropenem Sodium commercialization with susceptibility data, physician education, pharmacovigilance systems, and antibiotic stewardship requirements.

Manufacturers should strengthen quality-by-design practices, diversify active pharmaceutical ingredient sourcing, and maintain transparent documentation for regulators and procurement bodies. Commercial teams should segment markets by regulatory feasibility, diagnostic maturity, guideline fit, reimbursement potential, and prescriber familiarity. Digital tools and AI should be used to improve antimicrobial resistance surveillance, demand planning, supply-chain continuity, and compliance rather than to encourage inappropriate antibiotic use.

Research Methodology

This executive summary is developed using a structured secondary-research framework that emphasizes regulatory status, antimicrobial stewardship trends, clinical-use context, regional healthcare dynamics, and pharmaceutical supply-chain factors. Priority sources typically include public regulatory databases, national treatment guidance, peer-reviewed literature, World Health Organization antimicrobial resistance resources, and public health agency materials.

The methodology applies cross-validation across clinical, regulatory, and commercial evidence to avoid unsupported claims. Market insights are interpreted through qualitative triangulation rather than speculative sizing, with particular attention to approved-use geographies, resistance patterns, procurement models, manufacturing quality expectations, pharmacovigilance requirements, and the evolving role of digital surveillance in antibiotic management.

Conclusion

Faropenem Sodium occupies a focused but important position in the global antibiotic landscape as an oral penem option relevant to selected bacterial infections and stewardship-aware prescribing. Its opportunity is strongest where regulatory authorization, physician familiarity, diagnostic support, and reliable supply converge.

Future progress will depend less on broad promotion and more on evidence-based positioning, resistance-informed use, and high-quality manufacturing. Organizations that combine clinical credibility, responsible access, regional precision, and AI-enabled surveillance will be better placed to compete in the Faropenem Sodium market while supporting global antimicrobial resistance objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Faropenem Sodium Market, by Form
7.1. Syrup
7.2. Tablets
8. Faropenem Sodium Market, by Pack Size
8.1. Bottles
8.2. Sachets
9. Faropenem Sodium Market, by Therapeutic Application
9.1. Gynecological Infections
9.2. Respiratory Tract Infections
9.3. Skin & Soft Tissue Infections
9.4. Urinary Tract Infections (UTIs)
10. Faropenem Sodium Market, by Distribution Channel
10.1. Offline Pharmacy
10.1.1. Hospital Pharmacy
10.1.2. Retail Pharmacy
10.2. Online Pharmacy
11. Faropenem Sodium Market, by End User
11.1. Ambulatory Care Centers
11.2. Hospitals & Clinics
12. Asia-Pacific Faropenem Sodium Market
13. North America Faropenem Sodium Market
14. Latin America Faropenem Sodium Market
15. Europe Faropenem Sodium Market
16. Middle East Faropenem Sodium Market
17. Africa Faropenem Sodium Market
18. ASEAN Faropenem Sodium Market
19. GCC Faropenem Sodium Market
20. European Union Faropenem Sodium Market
21. BRICS Faropenem Sodium Market
22. G7 Faropenem Sodium Market
23. NATO Faropenem Sodium Market
24. United States Faropenem Sodium Market
25. China Faropenem Sodium Market
26. Germany Faropenem Sodium Market
27. India Faropenem Sodium Market
28. Japan Faropenem Sodium Market
29. United Kingdom Faropenem Sodium Market
30. Canada Faropenem Sodium Market
31. Russia Faropenem Sodium Market
32. Brazil Faropenem Sodium Market
33. Italy Faropenem Sodium Market
34. Mexico Faropenem Sodium Market
35. France Faropenem Sodium Market
36. Spain Faropenem Sodium Market
37. Australia Faropenem Sodium Market
38. South Korea Faropenem Sodium Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Adooq Bioscience LLC
40.2. Alkem Laboratories Ltd.
40.3. Angle Bio Pharma
40.4. Arlak Biotech Pvt. Ltd.
40.5. Asterisk Healthcare
40.6. Canagen Pharmaceuticals Inc.
40.7. Casca Remedies Pvt. Ltd.
40.8. Cipla Limited
40.9. Conscientia Industrial Co., Ltd.
40.10. Fawn Incor Pvt. Ltd.
40.11. G-Biosciences
40.12. Glenmark Pharmaceuticals Limited
40.13. Honour Lab Limited
40.14. Hunan Warrant Chiral Pharmaceutical Co., Ltd.
40.15. Jabs Biotech PVT. LTD.
40.16. Lunan Pharmaceutical Group Ltd.
40.17. Maruho Co., Ltd.
40.18. Metrochem API Private Limited
40.19. Neuracle Lifesciences Private Limited
40.20. Shandong Chenlong Pharmaceutical Co., Ltd.
40.21. SimSon Pharma Limited
List of Figures
FIGURE 1. GLOBAL FAROPENEM SODIUM MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FAROPENEM SODIUM MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FAROPENEM SODIUM MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FAROPENEM SODIUM MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FAROPENEM SODIUM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL FAROPENEM SODIUM MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CHINA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. CANADA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. BRAZIL FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. MEXICO FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. FRANCE FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FAROPENEM SODIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FAROPENEM SODIUM MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL FAROPENEM SODIUM MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SYRUP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SYRUP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SYRUP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BOTTLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BOTTLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BOTTLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SACHETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SACHETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SACHETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GYNECOLOGICAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GYNECOLOGICAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GYNECOLOGICAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY TRACT INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY TRACT INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY TRACT INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SKIN & SOFT TISSUE INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SKIN & SOFT TISSUE INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SKIN & SOFT TISSUE INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTIONS (UTIS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTIONS (UTIS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTIONS (UTIS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 57. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 58. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 59. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. EUROPE FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. EUROPE FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 78. EUROPE FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 79. EUROPE FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. EUROPE FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 82. EUROPE FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. AFRICA FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. AFRICA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 92. AFRICA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 93. AFRICA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. AFRICA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. AFRICA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 96. AFRICA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. ASEAN FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. ASEAN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 99. ASEAN FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 100. ASEAN FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. ASEAN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. ASEAN FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 103. ASEAN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. GCC FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GCC FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 106. GCC FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 107. GCC FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. GCC FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. GCC FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 110. GCC FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. BRICS FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. BRICS FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 120. BRICS FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 121. BRICS FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. BRICS FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. BRICS FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 124. BRICS FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. G7 FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. G7 FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 127. G7 FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 128. G7 FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. G7 FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. G7 FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 131. G7 FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. NATO FAROPENEM SODIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. NATO FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 134. NATO FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 135. NATO FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NATO FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. NATO FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 138. NATO FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. CHINA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 147. CHINA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 148. CHINA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 149. CHINA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. CHINA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. CHINA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 152. CHINA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GERMANY FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 154. GERMANY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 155. GERMANY FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 156. GERMANY FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. GERMANY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. GERMANY FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 159. GERMANY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. INDIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. INDIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 162. INDIA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 163. INDIA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. INDIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. INDIA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 166. INDIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. JAPAN FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 168. JAPAN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 169. JAPAN FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 170. JAPAN FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. JAPAN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. JAPAN FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 173. JAPAN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 175. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 176. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 177. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. CANADA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. CANADA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 183. CANADA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 184. CANADA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. CANADA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. CANADA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 187. CANADA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. RUSSIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 189. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 190. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 191. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 194. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. BRAZIL FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 197. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 198. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 201. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. ITALY FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. ITALY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 204. ITALY FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 205. ITALY FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. ITALY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. ITALY FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 208. ITALY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. MEXICO FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 210. MEXICO FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 211. MEXICO FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 212. MEXICO FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. MEXICO FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. MEXICO FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 215. MEXICO FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. FRANCE FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. FRANCE FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 218. FRANCE FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 219. FRANCE FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. FRANCE FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. FRANCE FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 222. FRANCE FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. SPAIN FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. SPAIN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 225. SPAIN FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 226. SPAIN FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. SPAIN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. SPAIN FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 229. SPAIN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 232. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 233. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 236. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 238. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 239. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY PACK SIZE, 2018-2032 (USD MILLION)
TABLE 240. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 243. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Faropenem Sodium market report include:
  • Adooq Bioscience LLC
  • Alkem Laboratories Ltd.
  • Angle Bio Pharma
  • Arlak Biotech Pvt. Ltd.
  • Asterisk Healthcare
  • Canagen Pharmaceuticals Inc.
  • Casca Remedies Pvt. Ltd.
  • Cipla Limited
  • Conscientia Industrial Co., Ltd.
  • Fawn Incor Pvt. Ltd.
  • G-Biosciences
  • Glenmark Pharmaceuticals Limited
  • Honour Lab Limited
  • Hunan Warrant Chiral Pharmaceutical Co., Ltd.
  • Jabs Biotech PVT. LTD.
  • Lunan Pharmaceutical Group Ltd.
  • Maruho Co., Ltd.
  • Metrochem API Private Limited
  • Neuracle Lifesciences Private Limited
  • Shandong Chenlong Pharmaceutical Co., Ltd.
  • SimSon Pharma Limited

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 277.1 Million
Forecasted Market Value ( USD ) by 2032 $ 427.87 Million
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Sulfachloropyrazine Sodium Market - Global Forecast 2026-2032 - Product Image

Sulfachloropyrazine Sodium Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Sodium Borohydride Market - Global Forecast 2026-2032 - Product Image

Sodium Borohydride Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
2025 Sodium Metal Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Sodium Metal Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 156 Pages
  • Global
From
2025 Sodium Methoxide Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Sodium Methoxide Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 155 Pages
  • Global
From
Sodium Cocoyl Glutamate - Global Strategic Business Report - Product Image

Sodium Cocoyl Glutamate - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.